Old Web
English
Sign In
Acemap
>
authorDetail
>
Kaku Saito
Kaku Saito
Deoxyuridine
CYP3A4
Pharmacology
Biology
Pharmacokinetics
3
Papers
35
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
First-in-human, phase I dose-escalation study of single and multiple doses of a first-in-class enhancer of fluoropyrimidines, a dUTPase inhibitor (TAS-114) in healthy male volunteers
2014
Cancer Chemotherapy and Pharmacology
Kaku Saito
Hirotaka Nagashima
Kazuharu Noguchi
Kunihiro Yoshisue
Tatsushi Yokogawa
Eiji Matsushima
Takeshi Tahara
Shigeru Takagi
Show All
Source
Cite
Save
Citations (27)
Abstract B90: First-in-human, phase I dose-escalation study of the pharmacokinetics and safety of single and multiple doses of a first-in-class enhancer of fluoropyrimidines, dUTPase inhibitor (TAS-114) in healthy male volunteers.
2013
Molecular Cancer Therapeutics
Kaku Saito
Hirotaka Nagashima
Kazuharu Noguchi
Kunihiro Yoshisue
Tatsushi Yokogawa
Eiji Matsushima
Takeshi Tahara
Shigeru Takagi
Teruhiro Utsugi
Show All
Source
Cite
Save
Citations (0)
Development of an air cushioning material based on a novel idea
1999
Packaging Technology and Science
Haruo Sasaki
Kaku Saito
Kaname Abe
Show All
Source
Cite
Save
Citations (8)
1